Mark Barakat

Retina Macula Institute

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Dilraj Grewal

Associate Professor of Ophthalmology

Duke University

UNITED STATES

View details

Arshad Khanani

University of Nevada

UNITED STATES

View details

Thomas A. Ciulla

Indiana University School of Medicine

UNITED STATES

View details

Debarshi Mustafi

University of Washington

UNITED STATES

View details

Jonathan Chang

University of Wisconsin-Madison

UNITED STATES

View details

Emmanuel Chang

Voluntary Assistant Professor

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mark Barakat

Research Interests

Explore related searches

Contact this professor

Articles (13)

Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial

Impact of Baseline Vision on Outcomes in Diabetic Macular Edema in VISTA/VIVID

Maculopathy after long-term use of fondaparinux, a heparin mimetic and heparanase inhibitor

Human Factors Studies to Assess the Usability of the Faricimab Prefilled Syringe

Safety and Efficacy of CLS-TA by Anatomic Location of Inflammation: Results from the Phase 3 PEACHTREE Clinical Trial

The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results

RETINAL VASCULITIS OR VASCULAR OCCLUSION AFTER BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: A Systematic Review of Real-World Evidence.

Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema

Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare Map.

Frequency of Urgent or Emergent Vitreoretinal Surgical Procedures in the United States During the COVID-19 Pandemic.

Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA).

Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA).

Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders.

Collaborators (6)

Dilraj Grewal

Arshad Khanani

Thomas A. Ciulla

Debarshi Mustafi

Jonathan Chang

Emmanuel Chang

Make your next move.